Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The facility sets a new benchmark in respiratory diagnostics
Subscribe To Our Newsletter & Stay Updated
